微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.36% | -78.05% | -92.71% | 94/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 4.94% | 55.35% | 32.09% | 62/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 3.74% | 2.19% | 28.52% | 69/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.91% | 39.23% | 77.44% | 64/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.64% | 256.52% | -48.43% | 59/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 3.18% | -90.19% | -13.11% | 80/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.66% | -90.04% | 75.12% | 76/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.09% | -93.09% | 354.35% | 83/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 0.46% | -97.8% | -98.58% | 98/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 32.42% | -58.04% | -11.76% | 11/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 36.74% | -58.94% | 21.49% | 10/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 30.24% | -61.26% | 44.48% | 9/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 20.93% | 2% | -72.91% | 9/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 77.27% | -44.6% | -13.65% | 3/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 89.48% | 2% | 14.64% | 3/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 78.05% | -27.82% | -44.04% | 3/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 139.48% | 511.75% | 28.99% | 3/131 | 25.69% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 108.13% | 2% | 374.25% | 1/131 | 15.16% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 22.8% | 19.06% | 19.06% | 29/131 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 19.15% | 3345.76% | 3345.76% | 34/131 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | -0.59% | 2% | 2% | 95/131 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |